Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Sell

C

Accelerate Diagnostics, Inc. (AXDX)

Laboratory Analytical Instruments

https://www.acceleratediagnostics.com

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

3950 S. COUNTRY CLUB ROAD #470, BUILDING 3-307
TUCSON, AZ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/19/1996

Market Cap

38,479,025

Shares Outstanding

14,760,000

Weighted SO

14,569,500

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

CVRX --.--%

NPCE --.--%

ANIK --.--%

AXGN --.--%

AORT --.--%

SGHT --.--%

OFIX --.--%

AVNS --.--%

CNMD --.--%

Beta

0.5740

Last Div

0.0000

Range

0.73-7.25

Chg

-0.0450

Avg Vol

75067

Mkt Cap

38479025

Exch

NASDAQ

Country

US

Phone

520 365 3100

DCF Diff

0.7123

DCF

1.7323

Div Yield

0.0000

P/S

3.1525

EV Multiple

-1.8916

P/FV

-1.0740

Div Yield %

0.0000

P/E

-0.9884

PEG

-0.1391

Payout

0.0000

Current Ratio

1.2801

Quick Ratio

1.0398

Cash Ratio

0.6403

DSO

68.4487

DIO

116.5440

Op Cycle

184.9927

DPO

135.9258

CCC

49.0669

Gross Margin

0.1730

Op Margin

-3.4255

Pretax Margin

-3.0486

Net Margin

-3.1057

Eff Tax Rate

-0.0406

ROA

-1.6578

ROE

1.3118

ROCE

-4.4227

NI/EBT

1.0187

EBT/EBIT

0.8900

EBIT/Rev

-3.4255

Debt Ratio

1.8485

D/E

-1.2116

LT Debt/Cap

6.6497

Total Debt/Cap

5.7253

Int Coverage

-9.9695

CF/Debt

-0.7581

Equity Multi

-0.6555

Rec Turnover

5.3325

Pay Turnover

2.6853

Inv Turnover

3.1319

FA Turnover

2.5350

Asset Turnover

0.5338

OCF/Share

-1.3897

FCF/Share

-1.4496

Cash/Share

0.4227

OCF/Sales

-2.6252

FCF/OCF

1.0432

CF Coverage

-0.7581

ST Coverage

-26.5257

CapEx Coverage

-23.1692

Div&CapEx Cov

-23.1692

P/BV

-1.0740

P/B

-1.0740

P/S

3.1525

P/E

-0.9884

P/FCF

-1.1512

P/OCF

-1.1693

P/CF

-1.1693

PEG

-0.1391

P/S

3.1525

EV Multiple

-1.8916

P/FV

-1.0740

DPS

0.0000

Latest Headlines (EST)

Benzinga Oct 25, 20:30 Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results

Revenue Product Segmentation